Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

3×5 Special Opportunity Fund

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 13
Average round size
info
The average size of a deal this fund participated in
$28M
Portfolio companies 8
Rounds per year 1.00
Lead investments 2
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.38
Exits 4
Key employees Soon
Stages of investment
Early Stage Venture
Late Stage Venture

Areas of investment

  • Biotechnology
  • Health Care
  • Medical Device
  • Cloud Computing
  • Analytics
Summary

3x5 Special Opportunity Fund is the famous VC, which was founded in 2011. The main office of represented VC is situated in the St Louis. The fund was located in North America if to be more exact in United States.

The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the 3x5 Special Opportunity Fund, startups are often financed by RiverVest, QuestMark Partners, Kaiser Permanente Ventures. The meaningful sponsors for the fund in investment in the same round are RiverVest, merrickhanna ventures, Sofinnova Investments. In the next rounds fund is usually obtained by Morgenthaler Ventures, Adage Capital Management, RiverVest.

The real fund results show that this VC is 5 percentage points more often commits exit comparing to other companies. The top activity for fund was in 2014. Despite it in 2019 the fund had an activity. The usual things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in less than 2 deals per year. The higher amount of exits for fund were in 2018. This 3x5 Special Opportunity Fund works on 4 percentage points more the average amount of lead investments comparing to the other organizations.

The fund has exact preference in a number of founders of portfolio startups. If startup sums 3 or 4 of the founder, the chance for it to be financed is low. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most successful fund investment fields, there are Wireless, Analytics. Among the most popular portfolio startups of the fund, we may highlight ZS Pharma, Arch Oncology, Tryton Medical. Besides, a startup needs to be aged 6-10 years to get the investment from the fund.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of 3×5 Special Opportunity Fund:
Typical Co-investors
3×5 Special Opportunity Fund is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after 3×5 Special Opportunity Fund:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Fervo Energy

Clean Energy
Energy
Environmental Engineering
Renewable Energy
$28M30 Apr 2021 Berkeley, California, United States

Arch Oncology

Biotechnology
$50M25 Mar 2019 California, United States

Amplyx Pharmaceuticals

Biotechnology
Clinical Trials
Medical
Pharmaceutical
$67M01 Aug 2017 San Diego, California, United States

Securus Medical Group

Biotechnology
Life Science
$10M15 Sep 2016 Cleveland, Ohio, United States

Amplyx Pharmaceuticals

Biotechnology
Clinical Trials
Medical
Pharmaceutical
$8M09 Feb 2016 San Diego, California, United States

Vapotherm

Biotechnology
Health Care
Medical Device
$24M03 Apr 2014 New Hampshire, United States

Securus Medical Group

Biotechnology
Life Science
$6M29 Oct 2013 Cleveland, Ohio, United States

Vapotherm

Biotechnology
Health Care
Medical Device
$29M25 Apr 2013 New Hampshire, United States

Vendscreen

Analytics
Cloud Computing
Payments
Wireless
$8M09 Dec 2012 Portland, Oregon, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent 3×5 Special Opportunity Fund?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 13
Average round size 28M
Rounds per year 1.00
Peak activity year 2014
Lead investments 2
Follow on index 0.38
Exits 4
Group Appearance index 0.92

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Fervo Energy

Clean Energy
Energy
Environmental Engineering
Renewable Energy
$28M30 Apr 2021 Berkeley, California, United States

Arch Oncology

Biotechnology
$50M25 Mar 2019 California, United States

Amplyx Pharmaceuticals

Biotechnology
Clinical Trials
Medical
Pharmaceutical
$67M01 Aug 2017 San Diego, California, United States

Securus Medical Group

Biotechnology
Life Science
$10M15 Sep 2016 Cleveland, Ohio, United States

Amplyx Pharmaceuticals

Biotechnology
Clinical Trials
Medical
Pharmaceutical
$8M09 Feb 2016 San Diego, California, United States

Vapotherm

Biotechnology
Health Care
Medical Device
$24M03 Apr 2014 New Hampshire, United States

Securus Medical Group

Biotechnology
Life Science
$6M29 Oct 2013 Cleveland, Ohio, United States

Vapotherm

Biotechnology
Health Care
Medical Device
$29M25 Apr 2013 New Hampshire, United States

Vendscreen

Analytics
Cloud Computing
Payments
Wireless
$8M09 Dec 2012 Portland, Oregon, United States
Crunchbase icon

Content report

The following text will be sent to our editors: